Search results
Results From The WOW.Com Content Network
Cancer Discovery publishes major advances in cancer research and clinical trials, with an impact factor of 30.6. The journal also features news and research watch sections on topics such as cancer cachexia, glioblastoma, and ALK-mutant oncoproteins.
Cancer Discovery is a peer-reviewed journal of the American Association for Cancer Research (AACR) that publishes high-impact cancer research. According to Clarivate, its 2024 impact factor is 30.6, ranking it among the top journals in the field.
Cancer Discovery is a monthly medical journal published by the American Association for Cancer Research. It covers research and clinical trials related to the study of cancer and has a high impact factor of 39.397.
Cancer Discovery is a peer-reviewed journal that publishes high-impact articles on cancer research and medicine. It has a print ISSN of 2159-8274 and an online ISSN of 2159-8290, but no impact factor is provided on the web page.
Cancer Discovery is a high-impact journal in oncology published by the American Association for Cancer Research. It has a SJR of 7.533 and a cites per document of 10.790 for 2023, ranking it in the first quartile of oncology journals.
Cancer Discovery Impact Factor, IF, number of article, detailed information and journal factor. ISSN: 2159-8274.
The impact factor for Cancer Discovery has more than tripled, and is now 39.397, according to Journal Citation Reports TM from Clarivate, 2021, released on Wednesday. “The incredible growth of the journal’s impact factor reflects Cancer Discovery’s importance to cancer researchers around the world,” said Foti. “The journal’s content ...
e-ISSN: 2159-8290. Cancer Discovery publishes high-impact, peer-reviewed articles describing major advances in research and clinical trials.
Cancer Discovery is a Q1 oncology journal with an impact factor of 9.34 in 2022, according to Scopus data. Find out its h-index, SJR, publisher, ISSN, and other important details on Resurchify.
Cancer Discovery is a hybrid and open access journal in oncology with a high impact factor of 29.7 and a 5-year impact factor of 32.4. It is ranked as the best journal in its category and has a percentage rank of 97.5% in WoS Core.